Capital Asset Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

Capital Asset Advisory Services’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.01M	Buy	7,618 +329	+5%	+$179K	0.15%	80
2025 Q4	$4.52M	Sell	7,289 -1,295	-15%	-$732K	0.18%	72
2025 Q3	$4.16M	Buy	8,584 +2,070	+32%	+$964K	0.18%	71
2025 Q2	$2.75M	Sell	6,514 -98	-1%	-$41K	0.13%	97
2025 Q1	$3.23M	Buy	6,612 +537	+9%	+$291K	0.16%	85
2024 Q4	$3.23M	Buy	6,075 +127	+2%	+$69.8K	0.16%	87
2024 Q3	$3.54M	Buy	5,948 +308	+5%	+$182K	0.18%	74
2024 Q2	$3M	Buy	5,640 +1,362	+32%	+$780K	0.16%	77
2024 Q1	$2.48M	Sell	4,278 -318	-7%	-$178K	0.14%	90
2023 Q4	$2.44M	Buy	4,596 +173	+4%	+$83.7K	0.15%	86
2023 Q3	$2.18M	Buy	4,423 +385	+10%	+$205K	0.15%	82
2023 Q2	$2.14M	Buy	4,038 +191	+5%	+$103K	0.15%	78
2023 Q1	$2.22M	Buy	3,847 +93	+2%	+$52.4K	0.16%	73
2022 Q4	$2.11M	Sell	3,754 -194	-5%	-$103K	0.17%	72
2022 Q3	$2M	Sell	3,948 -225	-5%	-$126K	0.26%	51
2022 Q2	$2.27M	Sell	4,173 -123	-3%	-$67.7K	0.25%	60
2022 Q1	$2.54M	Buy	4,296 +1,181	+38%	+$678K	0.27%	54
2021 Q4	$2.08M	Buy	3,115 +522	+20%	+$326K	0.22%	62
2021 Q3	$1.48M	Buy	2,593 +773	+42%	+$424K	0.17%	85
2021 Q2	$919K	Buy	1,820 +157	+9%	+$74.1K	0.1%	144
2021 Q1	$759K	Buy	1,663 +258	+18%	+$123K	0.11%	168
2020 Q4	$655K	Buy	1,405 +380	+37%	+$178K	0.12%	153
2020 Q3	$453K	Buy	1,025 +10	+1%	+$4.13K	0.09%	176
2020 Q2	$413K	Buy	1,015 +95	+10%	+$31.8K	0.09%	204
2020 Q1	$307K	Buy	920 +45	+5%	+$14.2K	0.08%	215
2019 Q4	$296K	Buy	+875	New	+$265K	0.07%	272

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Asset Advisory Services's TMO Position: Q1 2026 in Review

Capital Asset Advisory Services increased its Thermo Fisher Scientific (TMO) stake by 4.5% in Q1 2026, buying an estimated $179K and bringing the position to 7,618 shares worth $4.01M. The position accounts for 0.15% of the portfolio, ranked #80.

Capital Asset Advisory Services first reported a position in TMO in Q4 2019 and has held it in 26 quarters since. The position peaked at $4.52M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Capital Asset Advisory Services held 7,618 shares of Thermo Fisher Scientific worth $4.01M as of Q1 2026.
Capital Asset Advisory Services bought 329 Thermo Fisher Scientific shares in Q1 2026, an estimated $179K.
Thermo Fisher Scientific made up 0.15% of Capital Asset Advisory Services's portfolio in Q1 2026, its #80 holding.
Capital Asset Advisory Services first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 26 quarters since.
Capital Asset Advisory Services's Thermo Fisher Scientific position peaked at $4.52M in Q4 2025.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Capital Asset Advisory Services's 13F filing for Q1 2026, filed 24 Apr 2026.